Eli Lilly and Co Analyst Ratings
BenzingaApr 18 09:53 ET
Eli Lilly Stock (NYSE:LLY): Hold Off Until the End of the Month
TipRanksApr 17 14:25 ET
Eli Lilly and Co Analyst Ratings
BenzingaApr 15 14:29 ET
Eli Lilly and Co Analyst Ratings
BenzingaApr 11 09:04 ET
Goldman Sachs Maintains Neutral on Eli Lilly and Co, Raises Price Target to $723
BenzingaApr 11 09:05 ET
Eli Lilly and Co Analyst Ratings
BenzingaApr 5 09:23 ET
Eli Lilly and Co Analyst Ratings
BenzingaApr 3 13:29 ET
Eli Lilly and Co Analyst Ratings
BenzingaApr 2 15:50 ET
Eli Lilly and Co Analyst Ratings
BenzingaApr 1 08:35 ET
Eli Lilly and Co Analyst Ratings
BenzingaMar 22 14:44 ET
Eli Lilly and Co Analyst Ratings
BenzingaMar 15 10:04 ET
Wells Fargo Sticks to Its Buy Rating for Eli Lilly & Co (LLY)
TipRanksMar 15 05:17 ET
Research Alert: CFRA Adds Eli Lilly To The High-quality Capital Appreciation Portfolio
MT NewswiresMar 13 12:20 ET
Research Alert: CFRA Adds Eli Lilly To The High-quality Capital Appreciation Portfolio
MT NewswiresMar 5 23:45 ET
Eli Lilly and Co Analyst Ratings
BenzingaMar 1 12:41 ET
Jim Cramer Weighs In On Palo Alto, Eli Lilly And Salesforce, Says Price Target Bump For This Stock A 'Red Flag'
BenzingaFeb 28 03:59 ET
Eli Lilly Analyst Ratings
BenzingaFeb 20 12:38 ET
Eli Lilly Analyst Ratings
BenzingaFeb 16 10:57 ET
Morgan Stanley Raises Price Target on Eli Lilly to $950 From $805, Keeps Overweight Rating
MT NewswiresFeb 16 07:46 ET
Eli Lilly Analyst Ratings
BenzingaFeb 14 11:29 ET
No Data
No Data